Is a complete ACAD research report available?

No complete published report is available for ACADIA Pharmaceuticals Inc. (ACAD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ACADIA Pharmaceuticals Inc. (ACAD)

NASDAQ: ACAD · USD

$20.3

+0.13 (+0.6%)· Recorded snapshot

Market cap	3.5B
Revenue (ttm)	1.1B
Net income (ttm)	380.5M
EPS (ttm)	$2.21
Shares out	172.3M
P/E (trailing)	9.2x
P/E (forward)	25.8x
Volume	962,940
Beta	0.89

Market data

Price

Recent price action with selectable time range.

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Tut

Metric	Value
Amount currency	USD
CIK code	0001070494
Company name	ACADIA Pharmaceuticals Inc.
Country	United States
Country code	US
CUSIP number	004225108
Earnings date	2026-11-04
Earnings time	amc
Employees	798
Employees change	144
Employees growth	22.02%
Enterprise value	$2.6B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1993
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2004-05-27
Is primary listing	Yes
Is SPAC	No
ISIN number	US0042251084
Last 10-K release date	2026-02-26
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$3.5B
Market cap category	Mid-Cap
Next earnings date	2026-11-04
Options	Yes
Price	$20.30
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	ACAD
U.S. state	California
Website	https://acadia.com

Metric

Value

Amount currency

USD

CIK code

0001070494

Company name

ACADIA Pharmaceuticals Inc.

Country

United States

Country code

CUSIP number

004225108

Earnings date

2026-11-04

Earnings time

amc

Employees

798

Employees change

144

Employees growth

22.02%

Enterprise value

$2.6B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1993

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2004-05-27

Is primary listing

Yes

Is SPAC

ISIN number

US0042251084

Last 10-K release date

2026-02-26

Last earnings date

2026-08-04

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$3.5B

Market cap category

Mid-Cap

Next earnings date

2026-11-04

Options

Yes

Price

$20.30

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

ACAD

U.S. state

California

Website

https://acadia.com

Metric	Value
Adjusted P/E ratio	26.8x
Average P/E ratio (3Y)	21.82x
Earnings yield	10.87%
EV/Earnings	6.86x
EV/EBIT	30.24x
EV/EBITDA	26.54x
EV/FCF	17.93x
EV/Sales	2.29x
FCF / EV yield	5.58%
FCF yield	4.17%
Forward EV/Sales	1.86x
Forward P/E	25.79x
Forward P/S	2.49x
Graham number	19.40991
Graham upside	-4.29%
P/(FCF - SBC) ratio	39.9x
P/(OCF - SBC) ratio	34.17x
P/B ratio	2.66x
P/E ratio	9.2x
P/FCF ratio	24x
P/OCF ratio	21.8x
P/S ratio	3.07x
Price / tangible book value	2.9x
Price/EBITDA ratio	35.51x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Adjusted P/E ratio

26.8x

Average P/E ratio (3Y)

21.82x

Earnings yield

10.87%

EV/Earnings

6.86x

EV/EBIT

30.24x

EV/EBITDA

26.54x

EV/FCF

17.93x

EV/Sales

2.29x

FCF / EV yield

5.58%

FCF yield

4.17%

Forward EV/Sales

1.86x

Forward P/E

25.79x

Forward P/S

2.49x

Graham number

19.40991

Graham upside

-4.29%

P/(FCF - SBC) ratio

39.9x

P/(OCF - SBC) ratio

34.17x

P/B ratio

2.66x

P/E ratio

9.2x

P/FCF ratio

24x

P/OCF ratio

21.8x

P/S ratio

3.07x

Price / tangible book value

2.9x

Price/EBITDA ratio

35.51x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
EBIT margin	7.59%
EBITDA margin	8.64%
FCF margin	12.79%
Gross margin	62.06%
Operating margin	7.59%
Pretax margin	10.66%
Profit margin	33.42%
Profit per employee	$476,797
Profitable quarters	11
Profitable years	2
Revenue per employee	$1.4M
ROA	3.64%
ROA (5Y)	-6.55%
ROCE	6.25%
ROE	35.74%
ROE (5Y)	-2.12%
ROIC	19.82%
SBC / revenue	5.1%
Tax / revenue	-22.76%

Metric

Value

EBIT margin

7.59%

EBITDA margin

8.64%

FCF margin

12.79%

Gross margin

62.06%

Operating margin

7.59%

Pretax margin

10.66%

Profit margin

33.42%

Profit per employee

$476,797

Profitable quarters

Profitable years

Revenue per employee

$1.4M

ROA

3.64%

ROA (5Y)

-6.55%

ROCE

6.25%

ROE

35.74%

ROE (5Y)

-2.12%

ROIC

19.82%

SBC / revenue

5.1%

Tax / revenue

-22.76%

Metric	Value
EPS growth	66.4%
EPS growth (Q)	13.29%
EPS growth (QoQ)	800%
EPS growth quarters	1
EPS growth years	3
FCF growth	-22.16%
FCF growth (Q)	50.32%
FCF growth (QoQ)	232.62%
Gross profit growth	15.18%
Gross profit growth (Q)	19.42%
Gross profit growth 3Y	40.97%
Gross profit growth 5Y	28.71%
Net income growth	71.27%
Net income growth (Q)	18.13%
Net income growth (QoQ)	766.1%
Net income growth quarters	1
Net income growth years	3
OCF growth	-14.68%
OCF growth (Q)	57.58%
OCF growth (QoQ)	196.58%
Operating income growth	-4.35%
Operating income growth (Q)	16.87%
Revenue growth	11.75%
Revenue growth (Q)	16.4%
Revenue growth (QoQ)	14.88%
Revenue growth 10Y	143.25%
Revenue growth 3Y	27.38%
Revenue growth 5Y	19.7%
Revenue growth quarters	15
Revenue growth years	10

Metric

Value

EPS growth

66.4%

EPS growth (Q)

13.29%

EPS growth (QoQ)

800%

EPS growth quarters

EPS growth years

FCF growth

-22.16%

FCF growth (Q)

50.32%

FCF growth (QoQ)

232.62%

Gross profit growth

15.18%

Gross profit growth (Q)

19.42%

Gross profit growth 3Y

40.97%

Gross profit growth 5Y

28.71%

Net income growth

71.27%

Net income growth (Q)

18.13%

Net income growth (QoQ)

766.1%

Net income growth quarters

Net income growth years

OCF growth

-14.68%

OCF growth (Q)

57.58%

OCF growth (QoQ)

196.58%

Operating income growth

-4.35%

Operating income growth (Q)

16.87%

Revenue growth

11.75%

Revenue growth (Q)

16.4%

Revenue growth (QoQ)

14.88%

Revenue growth 10Y

143.25%

Revenue growth 3Y

27.38%

Revenue growth 5Y

19.7%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-14.7M
Depreciation and amortization	$12M
EBIT	$86.4M
EBITDA	$98.4M
EPS	$2.21
FCF per share	$0.85
Financing cash flow	$46.8M
Free cash flow	$145.6M
Free cash flow minus SBC	$87.6M
Gross profit	$706.7M
Income taxes	$-259.1M
Investing cash flow	$-77.5M
Net cash flow	$129.7M
Net income	$380.5M
Operating cash flow minus SBC	$102.3M
Operating income	$86.4M
Revenue	$1.1B
Stock-based compensation	$58.1M

Metric

Value

Capital expenditures

$-14.7M

Depreciation and amortization

$12M

EBIT

$86.4M

EBITDA

$98.4M

EPS

$2.21

FCF per share

$0.85

Financing cash flow

$46.8M

Free cash flow

$145.6M

Free cash flow minus SBC

$87.6M

Gross profit

$706.7M

Income taxes

$-259.1M

Investing cash flow

$-77.5M

Net cash flow

$129.7M

Net income

$380.5M

Operating cash flow minus SBC

$102.3M

Operating income

$86.4M

Revenue

$1.1B

Stock-based compensation

$58.1M

Metric	Value
Altman Z-Score	5.43
Book value per share	$7.59
Debt / EBITDA	0.66
Debt / equity	0.06
Debt / FCF	0.51
Long-term assets	$518.4M
Long-term liabilities	$74.9M
Net cash (debt)	$882.6M
Net cash / market cap	25.26%
Net cash growth	25.07%
Net debt / EBITDA	-8.97
Net debt / equity	-0.68
Net debt / FCF	-6.06
Piotroski F-Score	5
Property, plant and equipment	$86.5M
Shareholders' equity	$1.3B
Tangible book value	$1.2B
Tangible book value per share	$6.99
Total assets	$1.7B
Total cash	$956.5M
Total debt	$73.9M
Total liabilities	$436.3M
WACC	8.94%

Metric

Value

Altman Z-Score

5.43

Book value per share

$7.59

Debt / EBITDA

0.66

Debt / equity

0.06

Debt / FCF

0.51

Long-term assets

$518.4M

Long-term liabilities

$74.9M

Net cash (debt)

$882.6M

Net cash / market cap

25.26%

Net cash growth

25.07%

Net debt / EBITDA

-8.97

Net debt / equity

-0.68

Net debt / FCF

-6.06

Piotroski F-Score

Property, plant and equipment

$86.5M

Shareholders' equity

$1.3B

Tangible book value

$1.2B

Tangible book value per share

$6.99

Total assets

$1.7B

Total cash

$956.5M

Total debt

$73.9M

Total liabilities

$436.3M

WACC

8.94%

Metric	Value
Asset turnover	0.77
Current assets	$1.2B
Current liabilities	$361.4M
Current ratio	3.39
Inventory turnover	14.77
Net working capital	$-79.1M
Quick ratio	3.11
Working capital	$863.1M
Working capital turnover	1.52

Metric

Value

Asset turnover

0.77

Current assets

$1.2B

Current liabilities

$361.4M

Current ratio

3.39

Inventory turnover

14.77

Net working capital

$-79.1M

Quick ratio

3.11

Working capital

$863.1M

Working capital turnover

1.52

Metric	Value
Buyback yield / dilution	-2.98%
Dividend yield	0%
Shareholder yield	-2.98%

Metric

Value

Buyback yield / dilution

-2.98%

Dividend yield

Shareholder yield

-2.98%

Metric	Value
10Y price change	-10.55%
10Y return CAGR	-1.11%
10Y total return	-10.55%
150-day SMA	$23.75
15Y price change	1,581.67%
15Y return CAGR	20.7%
15Y total return	1,581.67%
1D price change	0.64%
1M price change	-2.42%
1M total return	-2.42%
1W price change	-1.27%
1W total return	-1.27%
1Y price change	-12.22%
1Y return CAGR	-12.23%
1Y total return	-12.22%
20-day SMA	$19.77
200-day SMA	$23.74
20Y price change	110.87%
20Y return CAGR	3.8%
20Y total return	110.87%
3M price change	-20.52%
3M total return	-20.52%
3Y price change	-7.26%
3Y return CAGR	-2.48%
3Y total return	-7.26%
50-day SMA	$24.10
50-day SMA vs 200-day SMA	50over200
52-week high	$30.96
52-week high date	2026-08-19
52-week low	$18.39
52-week low date	2026-10-13
5Y price change	14.92%
5Y return CAGR	2.82%
5Y total return	14.92%
6M price change	-9.51%
6M total return	-9.51%
All-time high	$58.72
All-time high date	2020-07-07
All-time low	$0.65
All-time low date	2010-11-12
Average true range (ATR)	$0.69
Average volume	1.7M
Beta (1Y)	0.86
Beta (2Y)	1.16
Beta (5Y)	0.89
Change from 52-week high	-34.43%
Change from 52-week low	10.39%
Change from all-time high	-65.63%
Change from all-time low	3,004.62%
Change from open	1.1%
Day's gap	-0.45%
Dollar volume	$19.5M
High price	$20.30
Low price	$20.07
Monthly RSI	46.29
Open price	$20.08
Position in 52-week range	100%
Premarket change	-0.84%
Premarket close	$20.17
Premarket price	$20.00
Previous close	$20.17
Price vs 150-day SMA	-15.04%
Price vs 20-day SMA	2.08%
Price vs 200-day SMA	-15%
Price vs 50-day SMA	-16.25%
Relative volume	0.57
RSI	41.15
Sharpe ratio	-0.25
Sharpe ratio (3Y)	0.09
Sharpe ratio (5Y)	0.25
Sortino ratio	-0.2
Sortino ratio (3Y)	0.27
Sortino ratio (5Y)	0.48
Volume	962.9K
Weekly RSI	38.68
YTD price change	-24.45%
YTD total return	-24.45%

Metric

Value

10Y price change

-10.55%

10Y return CAGR

-1.11%

10Y total return

-10.55%

150-day SMA

$23.75

15Y price change

1,581.67%

15Y return CAGR

20.7%

15Y total return

1,581.67%

1D price change

0.64%

1M price change

-2.42%

1M total return

-2.42%

1W price change

-1.27%

1W total return

-1.27%

1Y price change

-12.22%

1Y return CAGR

-12.23%

1Y total return

-12.22%

20-day SMA

$19.77

200-day SMA

$23.74

20Y price change

110.87%

20Y return CAGR

3.8%

20Y total return

110.87%

3M price change

-20.52%

3M total return

-20.52%

3Y price change

-7.26%

3Y return CAGR

-2.48%

3Y total return

-7.26%

50-day SMA

$24.10

50-day SMA vs 200-day SMA

50over200

52-week high

$30.96

52-week high date

2026-08-19

52-week low

$18.39

52-week low date

2026-10-13

5Y price change

14.92%

5Y return CAGR

2.82%

5Y total return

14.92%

6M price change

-9.51%

6M total return

-9.51%

All-time high

$58.72

All-time high date

2020-07-07

All-time low

$0.65

All-time low date

2010-11-12

Average true range (ATR)

$0.69

Average volume

1.7M

Beta (1Y)

0.86

Beta (2Y)

1.16

Beta (5Y)

0.89

Change from 52-week high

-34.43%

Change from 52-week low

10.39%

Change from all-time high

-65.63%

Change from all-time low

3,004.62%

Change from open

1.1%

Day's gap

-0.45%

Dollar volume

$19.5M

High price

$20.30

Low price

$20.07

Monthly RSI

46.29

Open price

$20.08

Position in 52-week range

100%

Premarket change

-0.84%

Premarket close

$20.17

Premarket price

$20.00

Previous close

$20.17

Price vs 150-day SMA

-15.04%

Price vs 20-day SMA

2.08%

Price vs 200-day SMA

-15%

Price vs 50-day SMA

-16.25%

Relative volume

0.57

RSI

41.15

Sharpe ratio

-0.25

Sharpe ratio (3Y)

0.09

Sharpe ratio (5Y)

0.25

Sortino ratio

-0.2

Sortino ratio (3Y)

0.27

Sortino ratio (5Y)

0.48

Volume

962.9K

Weekly RSI

38.68

YTD price change

-24.45%

YTD total return

-24.45%

Metric	Value
Float	128.3M
Float percentage	74.49%
Shares change (QoQ)	0.08%
Shares change (YoY)	2.98%
Shares held by insiders	0.55%
Shares held by institutions	74.95%
Shares outstanding	172.3M
Short % of float	6.45%
Short % of shares	4.8%
Short ratio	3.9 days

Metric

Value

Float

128.3M

Float percentage

74.49%

Shares change (QoQ)

0.08%

Shares change (YoY)

2.98%

Shares held by insiders

0.55%

Shares held by institutions

74.95%

Shares outstanding

172.3M

Short % of float

6.45%

Short % of shares

4.8%

Short ratio

3.9 days

ACADIA Pharmaceuticals Inc. (ACAD)

Price

Financial snapshot

Fair-value bridge

Latest news · ACAD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ACAD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ACAD

Frequently asked questions